Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Subscribe To Our Newsletter & Stay Updated
